• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 14, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-1939-13
Classification Class II
Code Info W12701380967900; W12701380967700; W12701380968200; W12701380950700; W12701380953600; W12701380953400; W12701380953300; W12701380953700; W12701380953800; W12701381096600; W12701381096400; W12701380957500; W12701380705400; W12701380706400; W12701380706000; W12701380705100; W12701380706600; W12701380706100; W12701380707000; W12701380707400; W12701381054200; W12701381052100; W12701381053700; W12701381055400; W12701381052600; W12701381052400; W12701381054500; W12701381051700; W12701380719000; W12701380718200;
Product Distributed Qty 30 units
Reason For Recall Blood products, collected in a manner that may have compromised the sterility of the products, were distributed.

Event Detail

Event Id 65156
Product Type Biologics
Status Completed
Recalling Firm OneBlood, Inc. dba Southeastern Comm. Blood Center
City Tallahassee
State FL
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2013-04-02
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern Florida; Georgia